Outcome Measurement in Value-Based Payments

JAMA Oncol. 2017 Aug 1;3(8):1019-1020. doi: 10.1001/jamaoncol.2016.5375.

Authors

Samyukta Mullangi¹, Stephen Schleicher², Thomas W Feeley^{3

4}

Affiliations

¹ University of Michigan Health System, Ann Arbor.
² Memorial Sloan-Kettering Cancer Center, New York, New York.
³ The University of Texas MD Anderson Cancer Center, Houston.
⁴ Institute for Strategy and Competitiveness, Harvard Business School, Boston, Massachusetts.

PMID: 27918757
DOI: 10.1001/jamaoncol.2016.5375

No abstract available

MeSH terms

Centers for Medicare and Medicaid Services, U.S. / economics*
Centers for Medicare and Medicaid Services, U.S. / legislation & jurisprudence
Cost-Benefit Analysis
Government Regulation
Health Care Costs* / legislation & jurisprudence
Health Policy / economics
Humans
Medical Oncology / economics*
Medical Oncology / legislation & jurisprudence
Outcome Assessment, Health Care / economics*
Outcome Assessment, Health Care / legislation & jurisprudence
Policy Making
Quality Indicators, Health Care / economics
Treatment Outcome
United States
Value-Based Health Insurance / economics*